Atezolizumab-associated Dermatomyositis in Advanced Small-cell Lung Carcinoma

Dermatomyositis is a rare immune-related adverse event caused by immune checkpoint inhibitors. We herein report a 75-year-old Japanese man with small-cell lung carcinoma who developed dermatomyositis after the administration of atezolizumab. He developed rashes on day 13 and myalgia and motor weakne...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Yoshitaka, Aso, Mari, Nagasawa, Hikaru, Wada, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502675/
https://www.ncbi.nlm.nih.gov/pubmed/33776010
http://dx.doi.org/10.2169/internalmedicine.6917-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502675/
https://www.ncbi.nlm.nih.gov/pubmed/33776010
http://dx.doi.org/10.2169/internalmedicine.6917-20

Ejemplares similares